Marja‐Leena Lähdeaho

Author

Also Known As

M L Lahdeaho, M.-L. Lähdeaho, M.L. Lähdeaho, M.‐L. LÄHDEAHO, M.‐L. LÄhdeaho, M.‐L. Lähdeaho, Marja-Leena Lahdeaho, Marja-Leena Lähdeaho, Marja-leena Lahdeaho, Marja‐Leena Lähdeaho

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Tampere University Hospital Tampere University University of Helsinki Seinäjoki University of Applied Sciences

About

Marja‐Leena Lähdeaho is an author at Tampere University Hospital specializing in medicine, gastroenterology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	787
2	Gastroenterology	8	8	716
3	Public Health	1	1	41
4	Allergy	1	1	117
5	Clinical Nutrition	1	1	71

Marja‐Leena Lähdeaho

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Glutenase ALV003 Attenuates Gluten-Induced Mucosal Injury in Patients With Celiac Disease Marja‐Leena Lähdeaho, Katri Kaukinen, Kaija Laurila, Gastroenterology Food IntoleranceAutoimmune DiseaseImmunologyGastroenterologyPathology	2014	249
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease Detlef Schuppan, Markku Mäki, Knut E. A. Lundin, New England Journal of Medicine	2021	206
Validation of Morphometric Analyses of Small-Intestinal Biopsy Readouts in Celiac Disease Juha Taavela, Outi Koskinen, Heini Huhtala, PLoS ONE	2013	198
Altered Duodenal Microbiota Composition in Celiac Disease Patients Suffering From Persistent Symptoms on a Long-Term Gluten-Free Diet Pirjo Wacklin, Pilvi Laurikka, Katri Lindfors, The American Journal of Gastroenterology	2014	193
Changing Pattern of Childhood Coeliac Disease in Finland M Mäki, K. KALLONEN, Marja‐Leena Lähdeaho, Acta Paediatrica	1988	180
Probiotic With or Without Fiber Controls Body Fat Mass, Associated With Serum Zonulin, in Overweight and Obese Adults—Randomized Controlled Trial Lotta K. Stenman, Markus J. Lehtinen, Nils Meland, EBioMedicine	2016	159
No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease Joseph A. Murray, Ciarán P. Kelly, Peter H.R. Green, Gastroenterology Difference Between LatiglutenaseVillous AtrophyClinical PresentationCeliac DiseaseMedicine	2016	131
Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study Marja‐Leena Lähdeaho, Mika Scheinin, Pekka Vuotikka, The Lancet. Gastroenterology & hepatology NutritionFood IntoleranceAutoimmune DiseaseAllergyCoeliac Disease	2019	117
Presentation of Celiac Disease in Finnish Children Is No Longer Changing: A 50-Year Perspective Laura Kivelä, Katri Kaukinen, Marja‐Leena Lähdeaho, The Journal of Pediatrics Food Intolerance50-Year PerspectiveGastroenterologyPediatricsPediatric Gastroenterology	2015	94
Small- bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease Marja‐Leena Lähdeaho, Markku Mäki, Kaija Laurila, BMC Gastroenterology	2011	78

Page 1